Heartbeam Net Income
| BEAT Stock | USD 1.43 0.14 10.85% |
As of the 9th of February, Heartbeam retains the market risk adjusted performance of 0.3194, and Risk Adjusted Performance of 0.0513. Heartbeam technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Heartbeam Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -22.4 M | -21.2 M | |
| Net Loss | -17.5 M | -16.6 M | |
| Net Loss | -11.7 M | -11.1 M | |
| Net Loss | (0.66) | (0.69) | |
| Net Income Per E B T | 0.93 | 0.98 |
Heartbeam | Net Income | Build AI portfolio with Heartbeam Stock |
The evolution of Net Income for Heartbeam provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Heartbeam compares to historical norms and industry peers.
Latest Heartbeam's Net Income Growth Pattern
Below is the plot of the Net Income of Heartbeam over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Heartbeam financial statement analysis. It represents the amount of money remaining after all of Heartbeam operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Heartbeam's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heartbeam's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (19.45 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Heartbeam Net Income Regression Statistics
| Arithmetic Mean | (6,633,361) | |
| Geometric Mean | 11,721,611 | |
| Coefficient Of Variation | (380.88) | |
| Mean Deviation | 16,109,549 | |
| Median | (12,202,000) | |
| Standard Deviation | 25,265,261 | |
| Sample Variance | 638.3T | |
| Range | 114.9M | |
| R-Value | (0.01) | |
| Mean Square Error | 680.8T | |
| R-Squared | 0.000072 | |
| Significance | 0.97 | |
| Slope | (42,426) | |
| Total Sum of Squares | 10213.3T |
Heartbeam Net Income History
Other Fundumenentals of Heartbeam
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Heartbeam Net Income component correlations
Heartbeam Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Heartbeam is extremely important. It helps to project a fair market value of Heartbeam Stock properly, considering its historical fundamentals such as Net Income. Since Heartbeam's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heartbeam's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heartbeam's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Heartbeam introduce new products? Factors like these will boost the valuation of Heartbeam. Projected growth potential of Heartbeam fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Heartbeam listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heartbeam is measured differently than its book value, which is the value of Heartbeam that is recorded on the company's balance sheet. Investors also form their own opinion of Heartbeam's value that differs from its market value or its book value, called intrinsic value, which is Heartbeam's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Heartbeam's market value can be influenced by many factors that don't directly affect Heartbeam's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Heartbeam's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Heartbeam should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Heartbeam's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Heartbeam 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Heartbeam's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Heartbeam.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Heartbeam on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Heartbeam or generate 0.0% return on investment in Heartbeam over 90 days. Heartbeam is related to or competes with OneMedNet Corp, OS Therapies, Werewolf Therapeutics, Spruce Biosciences, IO Biotech, Spectral, and CervoMed. HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitor... More
Heartbeam Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Heartbeam's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Heartbeam upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.98 | |||
| Information Ratio | 0.0463 | |||
| Maximum Drawdown | 103.08 | |||
| Value At Risk | (11.73) | |||
| Potential Upside | 28.33 |
Heartbeam Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heartbeam's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Heartbeam's standard deviation. In reality, there are many statistical measures that can use Heartbeam historical prices to predict the future Heartbeam's volatility.| Risk Adjusted Performance | 0.0513 | |||
| Jensen Alpha | 0.6125 | |||
| Total Risk Alpha | (0.77) | |||
| Sortino Ratio | 0.0679 | |||
| Treynor Ratio | 0.3094 |
Heartbeam February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0513 | |||
| Market Risk Adjusted Performance | 0.3194 | |||
| Mean Deviation | 8.53 | |||
| Semi Deviation | 10.24 | |||
| Downside Deviation | 10.98 | |||
| Coefficient Of Variation | 1927.14 | |||
| Standard Deviation | 16.09 | |||
| Variance | 258.92 | |||
| Information Ratio | 0.0463 | |||
| Jensen Alpha | 0.6125 | |||
| Total Risk Alpha | (0.77) | |||
| Sortino Ratio | 0.0679 | |||
| Treynor Ratio | 0.3094 | |||
| Maximum Drawdown | 103.08 | |||
| Value At Risk | (11.73) | |||
| Potential Upside | 28.33 | |||
| Downside Variance | 120.46 | |||
| Semi Variance | 104.93 | |||
| Expected Short fall | (11.65) | |||
| Skewness | 2.54 | |||
| Kurtosis | 16.81 |
Heartbeam Backtested Returns
Heartbeam appears to be abnormally volatile, given 3 months investment horizon. Heartbeam holds Efficiency (Sharpe) Ratio of 0.0555, which attests that the entity had a 0.0555 % return per unit of standard deviation over the last 3 months. By evaluating Heartbeam's technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please utilize Heartbeam's market risk adjusted performance of 0.3194, and Risk Adjusted Performance of 0.0513 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Heartbeam holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of 2.67, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Heartbeam will likely underperform. Please check Heartbeam's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Heartbeam's current trending patterns will revert.
Auto-correlation | -0.64 |
Very good reverse predictability
Heartbeam has very good reverse predictability. Overlapping area represents the amount of predictability between Heartbeam time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Heartbeam price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Heartbeam price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Heartbeam Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Heartbeam reported net income of (19.45 Million). This is 105.7% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.41% higher than that of the company.
Heartbeam Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heartbeam's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heartbeam could also be used in its relative valuation, which is a method of valuing Heartbeam by comparing valuation metrics of similar companies.Heartbeam is currently under evaluation in net income category among its peers.
Heartbeam Institutional Holders
Institutional Holdings refers to the ownership stake in Heartbeam that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Heartbeam's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Heartbeam's value.| Shares | Spectrum Asset Management Inc | 2025-06-30 | 74.4 K | Sigma Planning Corp | 2025-06-30 | 73.8 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 72.7 K | Cannon Financial Strategists, Inc. | 2025-06-30 | 68.7 K | Advisory Research Inc | 2025-06-30 | 50 K | Northern Trust Corp | 2025-06-30 | 49.5 K | Susquehanna International Group, Llp | 2025-06-30 | 38.5 K | D'orazio & Associates Inc | 2025-06-30 | 33 K | Citadel Advisors Llc | 2025-06-30 | 29.6 K | Vanguard Group Inc | 2025-06-30 | 1.1 M | Smith, Salley & Associates, Llc | 2025-06-30 | 367.6 K |
Heartbeam Fundamentals
| Return On Equity | -7.92 | ||||
| Return On Asset | -2.72 | ||||
| Current Valuation | 47.4 M | ||||
| Shares Outstanding | 34.44 M | ||||
| Shares Owned By Insiders | 23.53 % | ||||
| Shares Owned By Institutions | 10.78 % | ||||
| Number Of Shares Shorted | 3.08 M | ||||
| Price To Earning | 149.92 X | ||||
| Price To Book | 121.32 X | ||||
| EBITDA | (19.88 M) | ||||
| Net Income | (19.45 M) | ||||
| Cash And Equivalents | 9.27 M | ||||
| Cash Per Share | 1.16 X | ||||
| Total Debt | 1.62 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 12.65 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (14.47 M) | ||||
| Short Ratio | 0.41 X | ||||
| Earnings Per Share | (0.66) X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 4.63 | ||||
| Number Of Employees | 16 | ||||
| Beta | -0.81 | ||||
| Market Capitalization | 49.25 M | ||||
| Total Asset | 3.28 M | ||||
| Retained Earnings | (56.27 M) | ||||
| Working Capital | 1.15 M | ||||
| Current Asset | 47.05 M | ||||
| Current Liabilities | 23.89 M | ||||
| Net Asset | 3.28 M |
About Heartbeam Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heartbeam's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heartbeam using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heartbeam based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.